课题基金 / 基金详情

Development of Aersolized Vaccines

Development of Aersolized Vaccines
雾化疫苗的开发
批准号:
7592437
负责人:
Mario Roederer
金额:
$45.97万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Mario Roederer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have demonstrated that aerosolized recombinant adenovirus is highly immunogenic when delivered to the lung of rhesus macaques. Specifically, this immunization generates very high levels of persistent CD4 and CD8 T cell responses in the lung, although very low levels throughout the rest of the body. Interestingly, we also find very good generation of antibody responses, both throughout the body and at various mucosal sites. Thus, this route may be very important for the generation of mucosal immune responses needed to protect against challenges such as HIV. But certainly, the high lung cellular responses are ideal for the possible protection against tuberculosis or influenza; we are in the process of immunizing with vectors against these pathogens and testing whether or not protection is seen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional And Phenotypic Characterization Of T Cells In
Develop Of Flow Cytometric Technologies For Immune Assay
Identification of HIV-specific B cells in blood
Development Of Flow Cytometric Technologies For Immune Assays
海外基金